Methylation of adrenergic β1 receptor is a potential epigenetic mechanism controlling antihypertensive response to metoprolol

Indian Journal of Biochemistry and Biophysics

Volumn 48, Issue 5, 2011, Pages 301-307

  Jiang, Qixia ^a,b   Yuan, Hong ^a   Xing, Xiaowei ^a   Liu, Jingjing ^a   Huang, Zhijun ^a   Du, Xia ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

1 adrenergic receptor; DNA methylation; Gene; Hypertension; Metoprolol

Indexed keywords

RATTUS; RODENTIA;

ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; BETA 1 ADRENERGIC RECEPTOR; METOPROLOL;

ANIMAL; ARTICLE; CULTURE TECHNIQUE; DNA METHYLATION; FEMALE; GENETIC EPIGENESIS; GENETICS; HEART MUSCLE; HUMAN; METABOLISM; RANDOMIZATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CELL CULTURE TECHNIQUES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; METOPROLOL; MYOCARDIUM; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, BETA-1;

EID: 80054942482     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jiang S, Hsu YH, Xu X, Xing H, Chen C, Niu T, Zhang Y, Peng S & Xu X (2004) Thromb Res 113, 361-369
2. Jiang S, Hsu YH, Niu T, Xu X, Xing H, Chen C, Wang X, Zhang Y, Peng S & Xu X (2005) Clin Exp Hypertens 27, 509-521
3. Cowley AW Jr (2006) Nat Rev Genet 7, 829-840
4. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD & Qu FY (2005) Chin J Epidemiol 26, 478-484
5. Ablad B, Carlsson B, Carlsson E, Dahlöf C, Ek L & Hultberg E (1974) Adv Cardiol 12, 290-302
6. Insel PA & Snavely MD (1981) Annu Rev Physiol 43, 625-636
7. Fain JN & Garcia-Sáinz JA (1983) J Lipid Res 24, 945-966
8. Sandilands AJ & O'Shaughnessy KM (2005) Br J Clin Pharmacol 60, 235-243
9. Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, Liu YZ, Li Q & Zhou HH (2006) Clin Pharmacol Ther 80, 23-32
10. Karlsson J, Lind L, Hallberg P, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F & Melhus H (2004) Clin Cardiol 27, 347-350
11. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Råstam L & Groop L (2001) Circulation 104, 187-190
12. Johnson J A, Zineh I, Puckett B J, McGorray S P, Yarandi H N & Pauly D F (2003) Clin Pharmacol Ther 74, 44-52
13. Schwartz G L & Turner S T (2004) Am J Pharmacogenom 4, 151-160
14. Yuan H, Huang ZJ, Yang GP, Lv HW, Sang HQ & Yao Y (2008) J Int Med Res 36, 1354-1362 (in Chinese)
15. Liu JJ, Huang ZJ, Xing XW, Lv HW, Yang GP, Peng JQ & Yuan H (2006) Chinese Medical Society of Cardiology, Council of the Eighth National Congress of Cardiology Series (in Chinese)
16. Hiltunen MO, Turunen MP, Häkkinen TP, Rutanen J, Hedman M, Mäkinen K, Turunen AM, Aalto-Setälä K & Ylä-Herttuala S (2002) Vasc Med 7, 5-11
17. Yuan H, Huang ZJ, Liu JJ, Xing XW, Jiang QX & Yang GP (2008) Cell Biol Int 32, abstract S7
18. Yuan H, Huang ZJ, Xing XW, Jiang QX & Yang GP (2008) Cell Biol Int 32, abstract S7-8
19. Drug Political Situation of Chinese Ministry of Health (1993) Beijing: People's Health Publishing House (in Chinese)
20. Okamato K & Aoki K (1963) Jpn Circ J 27, 282-293
21. Levy AP, Levy NS & Goldberg MA (1996) J Biol Chem 2715, 2746-2753
22. Laugwitz KL, Kronsbein K, Schmitt M, Hoffmann K, Seyfarth M, Schömig A & Ungerer M (1997) Cardiovasc Res 35, 324-333
23. Jones PA & Takai D (2001) Science 293, 1068-1070
24. Antequera F & Bird A (1993) Proc Natl Acad Sci (USA) 90, 11995-11999
25. Richardson B (2003) Ageing Res Rev 2, 245-261
26. Attwood JT & Yung RL (2002) Cell Mol Life Sci 59, 241-257
27. Alikhani-Koopaei R, Fouladkou F, Frey FJ & Frey BM (2004) J Clin Invest 114, 1146-1157
28. Friso S, Pizzolo F, Choi SW, Guarini P, Castagna A, Ravagnani V, Carletto A, Pattini P, Corrocher R & Olivieri O (2008) Atherosclerosis 199, 323-327
29. Bogdarina I, Welham S, King PJ, Burns SP & Clark AJ (2007) Circ Res 100, 520-526
30. Herman JG, Graff JR, Myöhänen S, Nelkin BD & Baylin SB (1996) Proc Natl Acad Sci (USA) 93, 9821-9826
31. Thomassin H, Kress C & Grange T (2004) Nucleic Acids Res 32, e168